Literature DB >> 21594611

Genomic medicine and neurological disease.

Philip M Boone1, Wojciech Wiszniewski, James R Lupski.   

Abstract

"Genomic medicine" refers to the diagnosis, optimized management, and treatment of disease--as well as screening, counseling, and disease gene identification--in the context of information provided by an individual patient's personal genome. Genomic medicine, to some extent synonymous with "personalized medicine," has been made possible by recent advances in genome technologies. Genomic medicine represents a new approach to health care and disease management that attempts to optimize the care of a patient based upon information gleaned from his or her personal genome sequence. In this review, we describe recent progress in genomic medicine as it relates to neurological disease. Many neurological disorders either segregate as Mendelian phenotypes or occur sporadically in association with a new mutation in a single gene. Heritability also contributes to other neurological conditions that appear to exhibit more complex genetics. In addition to discussing current knowledge in this field, we offer suggestions for maximizing the utility of genomic information in clinical practice as the field of genomic medicine unfolds.

Entities:  

Mesh:

Year:  2011        PMID: 21594611      PMCID: PMC3133694          DOI: 10.1007/s00439-011-1001-1

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  150 in total

1.  Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect.

Authors:  Jennifer A Lee; Ricardo E Madrid; Karen Sperle; Carolyn M Ritterson; Grace M Hobson; James Garbern; James R Lupski; Ken Inoue
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

Review 2.  The genetics of epilepsy--the past, the present and future.

Authors:  Mark I Rees
Journal:  Seizure       Date:  2010-11-20       Impact factor: 3.184

3.  Spinocerebellar degeneration associated with a selective defect of vitamin E absorption.

Authors:  A E Harding; S Matthews; S Jones; C J Ellis; I W Booth; D P Muller
Journal:  N Engl J Med       Date:  1985-07-04       Impact factor: 91.245

4.  Familial isolated vitamin E deficiency. Extensive study of a large family with a 5-year therapeutic follow-up.

Authors:  J Amiel; J C Maziere; I Beucler; M Koenig; L Reutenauer; N Loux; D Bonnefont; C Féo; P Landrieu
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 5.  Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies.

Authors:  E Nelis; N Haites; C Van Broeckhoven
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

Review 6.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

7.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.

Authors:  D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

8.  The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans.

Authors:  Feng Zhang; Mehrdad Khajavi; Anne M Connolly; Charles F Towne; Sat Dev Batish; James R Lupski
Journal:  Nat Genet       Date:  2009-06-21       Impact factor: 38.330

9.  Is gene discovery research or diagnosis?

Authors:  Mark E Samuels; Andrew Orr; Duane L Guernsey; Kent Dooley; Christie Riddell; Kathy Hodgkinson; Mark Ludman; Daryl Pullman
Journal:  Genet Med       Date:  2008-06       Impact factor: 8.822

10.  Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Authors:  Sreeram V Ramagopalan; Narelle J Maugeri; Lahiru Handunnetthi; Matthew R Lincoln; Sarah-Michelle Orton; David A Dyment; Gabriele C Deluca; Blanca M Herrera; Michael J Chao; A Dessa Sadovnick; George C Ebers; Julian C Knight
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more
  7 in total

1.  Assessing the integration of genomic medicine in genetic counseling training programs.

Authors:  Jessica Profato; Erynn S Gordon; Shannan Dixon; Andrea Kwan
Journal:  J Genet Couns       Date:  2014-01-08       Impact factor: 2.537

2.  Replicative mechanisms of CNV formation preferentially occur as intrachromosomal events: evidence from Potocki-Lupski duplication syndrome.

Authors:  Zhe Sun; Pengfei Liu; Xueyuan Jia; Marjorie A Withers; Li Jin; James R Lupski; Feng Zhang
Journal:  Hum Mol Genet       Date:  2012-11-16       Impact factor: 6.150

3.  Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease.

Authors:  Kinga Szigeti; Deepika Lal; Yanchun Li; Rachelle S Doody; Kirk Wilhelmsen; Li Yan; Song Liu; Changxing Ma
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 4.  De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention.

Authors:  Julie Gauthier; Guy A Rouleau
Journal:  Genome Med       Date:  2012-09-25       Impact factor: 11.117

5.  Constructing endophenotypes of complex diseases using non-negative matrix factorization and adjusted rand index.

Authors:  Hui-Min Wang; Ching-Lin Hsiao; Ai-Ru Hsieh; Ying-Chao Lin; Cathy S J Fann
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

6.  Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarray.

Authors:  Robin Z Hayeems; Ny Hoang; Sebastien Chenier; Dimitri J Stavropoulos; Shuye Pu; Rosanna Weksberg; Cheryl Shuman
Journal:  Eur J Hum Genet       Date:  2014-12-10       Impact factor: 4.246

7.  Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success.

Authors:  Vincent Timmerman; Alleene V Strickland; Stephan Züchner
Journal:  Genes (Basel)       Date:  2014-01-22       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.